The action of clenbuterol on sleep and symptomatology in depressives.

Abstract

Five female inpatients with major depression (melancholic type, DMS-III-R) were treated with the beta-adrenergic agonist clenbuterol for three weeks, with doses ranging from 100 micrograms to 150 micrograms. Remission of depressive symptomatology during treatment was observed in only one patient. All patients complained of side effects, especially tremor… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.